Hematologic Abnormalities and Acute Myeloid Leukemia in Children and Adolescents Administered Intensified Chemotherapy for the Ewing Sarcoma Family of Tumors

Alberto S. Pappo(St. Jude Children's Research Hospital), Catherine A. Poquette(St. Jude Children's Research Hospital), William H. Meyer(Lawrence Livermore National Laboratory), Victor M. Santana(St. Jude Children's Research Hospital), David R. Head(University of Southern California), Alvida M. Cain(St. Jude Children's Research Hospital), Neyssa Marina(Coherus BioSciences (United States))
˜The œAmerican journal of pediatric hematology/oncology
July 1, 2000
10.1097/00043426-200007000-00008
Cited by 47

Related Papers

Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
|Blood|1997|869